Response to the Canadian Agency for Drugs and Technologies in Health and Institut national d’excellence en santé et en services sociaux decision regarding nusinersen for Spinal Muscular Atrophy
Campbell, Craig, Selby, Kathy, McMillan, Hugh, Vajsar, Jiri, Korngut, Lawrence, Brais, Bernard, MacKenzie, Alex, Oskoui, MaryamLanguage:
english
Journal:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
DOI:
10.1017/cjn.2018.59
Date:
July, 2018
File:
PDF, 62 KB
english, 2018